The Kronic King

It is disappointing to read that Kronic businessman Matthew Wielenga has been arrested in Australia.

While the move towards regulation of party drugs in New Zealand is a step on the pathway to eventual decriminalisation, Australia has a different attitude.

Their close relationship to the United States is reflected in a far more aggressive drug enforcement policy, modelled along DEA lines.

Funnily enough, their strong drug enforcement policy has made them the most attractive cocaine market in the world for Mexican drug cartels.

If people actually care about health outcomes and public safety, are “legal” or “almost legal” highs a better alternative than products provided primarily by organised crime?

That’s the question parents really should ask. Do you want your kid to get something from a tinnie house or a business that could be sued for wrongful death or even the proposed “corporate manslaughter”?

I fail to see how arresting someone like this guy does anything towards reducing harm or lowering the role organised crime plays in the black and grey party product market.

Hundreds of millions of dollars a year in taxpayer money is wasted on drug enforcement. But actual crimes like fraud and burglarly aren’t a police priority.

It’s probably because when investigating a burglary, a cop doesn’t get to play “special forces soldier” for an afternoon whereas on a drug raid they can re-enact their favourite war movies.

When all of the baby boomers are dead, the hypocrisy of weed smoking and LSD taking hippies leading the anti-drug Nazism will hopefully be removed from our political system.

No one capable of thinking clearly cares about weed. Why care about Kronic?

The misleading spin put on questionable statistics have led to terrible policy decisions being pursued by a law enforcement cabal bent on eliminating mostly harmless fun from many peoples lives.

The global war on drugs is arguably the most disastrous policy failure in human history. How many more lives have to be ruined before change comes to drug policy?